Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination - The Lancet

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination - The Lancet The gist of this is that the older you are, the fewer antibodies you produce over time after having received the Pfizer vaccine, and this may have implications for the variants coming out of India that are now dominant in the Uk and are coming soon to a theater near you.